---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-025069"
form_type: "8-K"
ticker: "MBOT"
cik: "0000883975"
company_name: "Microbot Medical Inc."
filed_at: "2025-11-26T23:59:59+00:00"
generated_at: "2026-05-16T16:43:53.900839+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Microbot Medical's LIBERTY robotic system adopted by Emory University Hospital as first hospital worldwide

## Summary
- Emory University Hospital in Atlanta is first hospital globally to adopt Microbot's LIBERTY Endovascular Robotic System for patient care.
- Microbot and Emory collaborate to establish an Endovascular Robotics Program in interventional radiology.
- LIBERTY is FDA-cleared, single-use, remotely operated robotic system designed to reduce radiation exposure and physical strain.
- Company launched limited market release weeks ago; full market release expected at SIR conference in April 2026.
- Emory will use LIBERTY for procedures including liver tumor embolization, prostate artery embolization, and uterine fibroid embolization.

## SEC filing metadata
- accession: 0001493152-25-025069
- form_type: 8-K
- ticker: MBOT
- cik: 0000883975
- company_name: Microbot Medical Inc.
- filed_at: 2025-11-26T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.7
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/883975/000149315225025069/0001493152-25-025069-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/883975/000149315225025069/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-025069
- JSON: https://secwatch.observer/filing/0001493152-25-025069.json
- Plain text: https://secwatch.observer/filing/0001493152-25-025069.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.